Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-24
2010-02-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S264100, C514S264110, C514S265100, C514S386000, C544S265000, C544S277000, C544S280000, C548S312400
Reexamination Certificate
active
07662827
ABSTRACT:
Compounds of the formula (I), in which R, X, R1, R2, R3and R4have the meanings indicated in Claim (1), are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.
REFERENCES:
patent: 2007/0259910 (2007-11-01), Halley et al.
patent: 99/23091 (1999-05-01), None
patent: 99/32106 (1999-07-01), None
patent: 99/32110 (1999-07-01), None
patent: 99/32111 (1999-07-01), None
patent: 99/32455 (1999-07-01), None
patent: WO 99/32455 (1999-07-01), None
patent: 03/029209 (2003-04-01), None
patent: 2005/121147 (2005-12-01), None
patent: 2006/043090 (2006-04-01), None
patent: WO 06/043090 (2006-04-01), None
patent: 2006/061493 (2006-06-01), None
patent: 2006/072589 (2006-07-01), None
Morissette et al. “High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.” Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Crassier Helene
Hoelzemann Guenter
Rautenberg Wilfried
Arent & Fox LLP
Fierro Alicia L
Merck Patent GmbH
Saeed Kamal A
LandOfFree
Pyrazole derivatives having tyrosine kinase inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole derivatives having tyrosine kinase inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives having tyrosine kinase inhibitory activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4185945